Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of 2-chloroprocaine and morphine is used in epidural anesthesia, particularly following cesarean sections. However, there is a significant interaction between these two drugs that affects their clinical efficacy. 2-Chloroprocaine is an ester local anesthetic agent. When administered epidurally before morphine, it has been shown to diminish the efficacy and duration of epidural morphine analgesia compared to when morphine is administered after other local anesthetics like lidocaine. Even small doses of 2-chloroprocaine administered remotely from the time of morphine injection can interfere with the duration of epidural morphine analgesia. For example, in one study, patients who received 2-chloroprocaine for epidural catheter testing experienced a significantly shorter duration of morphine analgesia (median 16 hours) compared to those who received lidocaine (median 24 hours). ## Mechanism of Interaction The exact mechanism of the interaction between 2-chloroprocaine and morphine is unknown. Several possible explanations have been proposed, including differences in latency/duration of action, chemical interactions, or physiological effects. ## Clinical Implications This interaction is clinically significant as it can substantially reduce the pain relief duration provided by epidural morphine when 2-chloroprocaine is used prior to morphine administration. When planning epidural anesthesia followed by epidural morphine for postoperative pain management, clinicians should consider this interaction. Using alternative local anesthetics such as lidocaine or bupivacaine for epidural catheter testing or anesthesia may be preferable when epidural morphine will be administered for postoperative analgesia. While 2-chloroprocaine reduces the duration of morphine analgesia, it does not appear to alter the incidence of morphine-related side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-chloroprocaine + morphine.